Caricamento...
β(1)-Blockade increases maximal apnea duration in elite breath-hold divers
We hypothesized that the cardioselective β(1)-adrenoreceptor antagonist esmolol would improve maximal apnea duration in elite breath-hold divers. In elite national-level divers (n = 9), maximal apneas were performed in a randomized and counterbalanced order while receiving either iv esmolol (150 μg·...
Salvato in:
| Pubblicato in: | J Appl Physiol (1985) |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Physiological Society
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5407199/ https://ncbi.nlm.nih.gov/pubmed/27125844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/japplphysiol.00127.2016 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|